|
G |
Maob |
monoamine oxidase B |
decreases activity |
EXP |
barbituric acid analog results in decreased activity of MAOB protein |
CTD |
PMID:24300193 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions increases activity |
EXP |
Chromium inhibits the reaction [Alloxan results in increased activity of ACOX1 protein]; chromium tripicolinate inhibits the reaction [Alloxan results in increased activity of ACOX1 protein] |
CTD |
PMID:19693677 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
Alloxan results in decreased expression of ACTB mRNA |
CTD |
PMID:12137914 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
[Alloxan co-treated with Niacinamide] affects the expression of ADIPOQ protein |
CTD |
PMID:26429928 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
ISO EXP |
Alloxan results in decreased phosphorylation of AKT1 protein Phycocyanin inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:26827782 PMID:33359794 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
decreases expression increases expression multiple interactions |
EXP |
Alloxan results in decreased expression of APAF1 protein Alloxan results in increased expression of APAF1 protein Taurine inhibits the reaction [Alloxan results in increased expression of APAF1 protein] |
CTD |
PMID:21982801 PMID:23092809 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
multiple interactions decreases expression |
EXP |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of ATP2A1 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
decreases expression |
EXP |
Alloxan results in decreased expression of ATP2A2 protein |
CTD |
PMID:28483572 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression multiple interactions |
EXP |
Alloxan results in increased expression of BAD protein Taurine inhibits the reaction [Alloxan results in increased expression of BAD protein] |
CTD |
PMID:22138235 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP |
Taurine inhibits the reaction [Alloxan results in increased expression of BAX protein] |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
EXP |
Alloxan results in decreased expression of BCL2 protein Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2 protein] |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression multiple interactions |
EXP |
Alloxan results in decreased expression of BCL2L1 protein Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2L1 protein] |
CTD |
PMID:22138235 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases expression |
EXP |
D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP3 protein]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP3 protein modified form] |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions increases expression |
EXP |
Alloxan results in increased activity of CASP9 protein D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP9 protein]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein modified form]; Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein] Alloxan results in increased expression of CASP9 protein; Alloxan results in increased expression of CASP9 protein modified form |
CTD |
PMID:21982801 PMID:22138235 PMID:23092809 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases expression decreases activity |
EXP ISO |
3,4-dihydroxyphenylethanol inhibits the reaction [Alloxan results in decreased expression of CAT protein]; Chromium inhibits the reaction [Alloxan results in decreased activity of CAT protein]; chromium tripicolinate inhibits the reaction [Alloxan results in decreased activity of CAT protein]; D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Alloxan results in decreased expression of CAT protein] Plant Oils inhibits the reaction [Alloxan results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Alloxan results in decreased activity of CAT protein] |
CTD |
PMID:10871429 PMID:19393637 PMID:19693677 PMID:21982801 PMID:24946265 PMID:28419827 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of CCL2 protein]] |
CTD |
PMID:18949387 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
multiple interactions decreases expression |
EXP |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of COX4I1 protein] |
CTD |
PMID:28483572 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions affects localization |
EXP |
Taurine inhibits the reaction [Alloxan affects the localization of CYCS protein] |
CTD |
PMID:22138235 PMID:23092809 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Alloxan results in increased expression of DDIT3 mRNA; Alloxan results in increased expression of DDIT3 protein |
CTD |
PMID:30076216 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Foxp3 |
forkhead box P3 |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of FOXP3 protein platycodin D inhibits the reaction [Alloxan results in decreased expression of FOXP3 protein] |
CTD |
PMID:25887267 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
increases activity multiple interactions |
EXP |
Alloxan results in increased activity of G6PC1 protein Sodium Selenite inhibits the reaction [Alloxan results in increased activity of G6PC1 protein] |
CTD |
PMID:25779343 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gck |
glucokinase |
multiple interactions decreases expression |
ISO EXP |
Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]; Phycocyanin inhibits the reaction [Alloxan results in decreased expression of GCK protein] ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCK protein] Alloxan results in decreased expression of GCK mRNA; Alloxan results in decreased expression of GCK protein |
CTD |
PMID:12137914 PMID:26827782 PMID:33359794 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gckr |
glucokinase regulator |
decreases expression multiple interactions |
ISO |
Alloxan results in decreased expression of GCKR protein Phycocyanin inhibits the reaction [Alloxan results in decreased expression of GCKR protein] |
CTD |
PMID:26827782 |
|
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression multiple interactions |
EXP |
Alloxan results in decreased expression of GCLC mRNA; Alloxan results in decreased expression of GCLC protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]] |
CTD |
PMID:33359794 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
[Alloxan results in increased susceptibility to titanium dioxide] which results in increased activity of GPT protein |
CTD |
PMID:23873220 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity |
EXP |
D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased activity of GSR protein] |
CTD |
PMID:21982801 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression multiple interactions |
EXP |
Alloxan results in decreased expression of HMOX1 mRNA; Alloxan results in decreased expression of HMOX1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]] |
CTD |
PMID:33359794 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
Alloxan results in increased expression of HSPA5 mRNA |
CTD |
PMID:30076216 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [Cathelicidins results in increased expression of ICAM1 protein]] |
CTD |
PMID:18949387 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Alloxan results in decreased expression of and results in decreased secretion of IL10 protein; platycodin D inhibits the reaction [Alloxan results in decreased expression of and results in decreased secretion of IL10 protein] |
CTD |
PMID:25887267 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
decreases expression |
ISO |
Alloxan results in decreased expression of IL12B protein |
CTD |
PMID:16249388 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
Alloxan results in increased expression of and results in increased secretion of IL17A protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL17A protein] |
CTD |
PMID:25887267 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Alloxan results in increased expression of and results in increased secretion of IL1B protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL1B protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL1B protein] |
CTD |
PMID:25887267 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP ISO |
Taurine inhibits the reaction [Alloxan results in increased expression of IL6 protein] Alloxan results in increased expression of and results in increased secretion of IL6 protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL6 protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of IL6 protein] |
CTD |
PMID:22138235 PMID:25887267 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions decreases expression decreases secretion |
ISO EXP |
Plant Oils inhibits the reaction [Alloxan results in decreased expression of INS1 protein] Alloxan results in decreased secretion of INS1 protein [Alloxan co-treated with Homocysteine] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; [Sertraline binds to 2-Hydroxypropyl-beta-cyclodextrin] inhibits the reaction [Alloxan results in decreased expression of INS1 protein]; Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]; D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in decreased expression of INS1 protein]; ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; Plant Preparations inhibits the reaction [Alloxan results in decreased secretion of INS1 protein]; Sertraline inhibits the reaction [Alloxan results in decreased expression of INS1 protein] |
CTD |
PMID:19393637 PMID:21050842 PMID:21982801 PMID:26593071 PMID:27317948 PMID:28419827 PMID:33359794 More...
|
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Insr |
insulin receptor |
decreases phosphorylation multiple interactions |
EXP |
Alloxan results in decreased phosphorylation of INSR protein Taurine inhibits the reaction [Alloxan results in decreased phosphorylation of INSR protein] |
CTD |
PMID:22138235 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Irs1 |
insulin receptor substrate 1 |
decreases phosphorylation multiple interactions affects phosphorylation |
EXP ISO |
Alloxan results in decreased phosphorylation of IRS1 protein Phycocyanin inhibits the reaction [Alloxan affects the phosphorylation of IRS1 protein] Taurine inhibits the reaction [Alloxan results in decreased phosphorylation of IRS1 protein] |
CTD |
PMID:22138235 PMID:26827782 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
EXP |
Alloxan results in increased phosphorylation of MAPK1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:33359794 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
ginsenoside Rh4 inhibits the reaction [Alloxan results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:33359794 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mfn2 |
mitofusin 2 |
decreases expression multiple interactions |
EXP |
Alloxan results in decreased expression of MFN2 protein imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of MFN2 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mpo |
myeloperoxidase |
increases activity multiple interactions |
EXP |
Alloxan results in increased activity of MPO protein Taurine inhibits the reaction [Alloxan results in increased activity of MPO protein] |
CTD |
PMID:22138235 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Ndufa9 |
NADH:ubiquinone oxidoreductase subunit A9 |
multiple interactions decreases expression |
EXP |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of NDUFA9 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 4:159,659,242...159,688,034
Ensembl chr 4:159,659,242...159,688,018
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression multiple interactions affects localization |
EXP |
Alloxan results in decreased expression of NFE2L2 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]]; ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of HMOX1 protein]]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]] |
CTD |
PMID:33359794 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos1 |
nitric oxide synthase 1 |
decreases expression |
ISO |
Alloxan results in decreased expression of NOS1 mRNA |
CTD |
PMID:30076216 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
Alloxan results in increased expression of NOS2 mRNA |
CTD |
PMID:30076216 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression multiple interactions |
EXP |
Alloxan results in decreased expression of NQO1 mRNA; Alloxan results in decreased expression of NQO1 protein ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]; NFE2L2 protein affects the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of NQO1 protein]] |
CTD |
PMID:33359794 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
multiple interactions |
EXP |
Alloxan affects the reaction [imisopasem manganese results in increased expression of NRF1 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases degradation multiple interactions |
EXP |
Alloxan results in increased degradation of PARP1 protein D-Glucaric acid, 1,4-lactone inhibits the reaction [Alloxan results in increased degradation of PARP1 protein] |
CTD |
PMID:21982801 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
multiple interactions decreases expression |
EXP |
ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of PDX1 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of PDX1 protein] Alloxan results in decreased expression of PDX1 mRNA; Alloxan results in decreased expression of PDX1 protein |
CTD |
PMID:33359794 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions decreases expression |
EXP |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of PPARGC1A protein] |
CTD |
PMID:28483572 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression |
ISO EXP |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]] Taurine inhibits the reaction [Alloxan results in increased expression of RELA protein] |
CTD |
PMID:19020780 PMID:22138235 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rorc |
RAR-related orphan receptor C |
increases expression multiple interactions |
ISO |
Alloxan results in increased expression of RORC protein platycodin D inhibits the reaction [Alloxan results in increased expression of RORC protein] |
CTD |
PMID:25887267 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
multiple interactions decreases expression |
EXP |
imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of SDHA protein] |
CTD |
PMID:28483572 |
|
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
decreases expression multiple interactions |
ISO EXP |
Alloxan results in decreased expression of SLC2A2 mRNA ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA]; ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of SLC2A2 protein] Alloxan results in decreased expression of SLC2A2 mRNA; Alloxan results in decreased expression of SLC2A2 protein Glucose inhibits the reaction [Alloxan results in decreased expression of SLC2A2 mRNA] |
CTD |
PMID:12137914 PMID:33359794 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
affects localization decreases expression multiple interactions |
EXP ISO |
Alloxan affects the localization of SLC2A4 protein Alloxan results in decreased expression of SLC2A4 protein Quercetin inhibits the reaction [Alloxan results in decreased expression of SLC2A4 protein] imisopasem manganese inhibits the reaction [Alloxan results in decreased expression of SLC2A4 protein]; Taurine inhibits the reaction [Alloxan affects the localization of SLC2A4 protein] |
CTD |
PMID:22138235 PMID:24946265 PMID:28483572 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Sod1 |
superoxide dismutase 1 |
affects response to substance decreases activity multiple interactions |
ISO EXP |
SOD1 protein affects the susceptibility to Alloxan Alloxan results in decreased activity of SOD1 protein Sulfur Dioxide inhibits the reaction [Alloxan results in decreased activity of SOD1 protein] |
CTD |
PMID:10871429 PMID:18502742 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
Alloxan inhibits the reaction [Glucosamine inhibits the reaction [TNF results in increased phosphorylation of RELA protein]] Alloxan results in increased expression of and results in increased secretion of TNF protein; platycodin D inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of TNF protein]; Rosiglitazone inhibits the reaction [Alloxan results in increased expression of and results in increased secretion of TNF protein] Alloxan results in increased expression of TNF protein Taurine inhibits the reaction [Alloxan results in increased expression of TNF protein] |
CTD |
PMID:19020780 PMID:22138235 PMID:25887267 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
increases expression |
ISO |
Alloxan results in increased expression of TRPM7 mRNA; Alloxan results in increased expression of TRPM7 protein |
CTD |
PMID:30076216 |
|
NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
|
|
G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
increases expression multiple interactions |
EXP |
Alloxan results in increased expression of UQCRC2 protein imisopasem manganese promotes the reaction [Alloxan results in increased expression of UQCRC2 protein] |
CTD |
PMID:28483572 |
|
NCBI chr 1:175,167,933...175,198,499
Ensembl chr 1:175,167,894...175,199,453
|
|
G |
Xdh |
xanthine dehydrogenase |
increases activity multiple interactions |
EXP |
Alloxan results in increased activity of XDH protein Taurine inhibits the reaction [Alloxan results in increased activity of XDH protein] |
CTD |
PMID:22138235 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases metabolic processing |
ISO |
CYP2C19 protein results in increased metabolism of Hexobarbital |
CTD |
PMID:12464242 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Hexobarbital inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] |
CTD |
PMID:19299527 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
affects expression |
EXP |
Hexobarbital affects the expression of GABRG2 mRNA |
CTD |
PMID:9336343 |
|
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
|
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
Secobarbital results in increased expression of CYP1A2 mRNA |
CTD |
PMID:10064569 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Secobarbital inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] |
CTD |
PMID:19299527 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Secobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN mRNA] |
CTD |
PMID:15263067 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions |
ISO |
Secobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] |
CTD |
PMID:15263067 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
Secobarbital results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:15263067 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
Secobarbital results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:15263067 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Secobarbital results in increased activity of NR1I2 protein |
CTD |
PMID:21068194 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
Secobarbital inhibits the reaction [Guanosine 5'-O-(3-Thiotriphosphate) results in increased activity of RAC1 protein] |
CTD |
PMID:15263067 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|